Ptc Therapeutics (PTCT) Research & Development (2016 - 2025)
Historic Research & Development for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $100.2 million.
- Ptc Therapeutics' Research & Development fell 3794.89% to $100.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $446.9 million, marking a year-over-year decrease of 1584.97%. This contributed to the annual value of $534.5 million for FY2024, which is 1981.55% down from last year.
- As of Q3 2025, Ptc Therapeutics' Research & Development stood at $100.2 million, which was down 3794.89% from $113.0 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Research & Development registered a high of $195.1 million during Q1 2023, and its lowest value of $100.2 million during Q3 2025.
- Its 5-year average for Research & Development is $142.9 million, with a median of $134.5 million in 2021.
- Per our database at Business Quant, Ptc Therapeutics' Research & Development surged by 4928.14% in 2021 and then tumbled by 4048.45% in 2024.
- Quarter analysis of 5 years shows Ptc Therapeutics' Research & Development stood at $149.8 million in 2021, then increased by 25.93% to $188.7 million in 2022, then plummeted by 35.69% to $121.4 million in 2023, then increased by 2.82% to $124.8 million in 2024, then dropped by 19.73% to $100.2 million in 2025.
- Its Research & Development was $100.2 million in Q3 2025, compared to $113.0 million in Q2 2025 and $109.0 million in Q1 2025.